Get started
Author

Josefina Cruz Jurado

Observed names: J Cruz Jurado, J. Cruz, J. Cruz Jurado, J. Jurado, J.C. Jurado, J.C.r.u.z. Jurado, Josefina Cruz, Josefina Cruz-Jurado
ORCID: 0000-0001-6398-1641
Observed ORCID: 0000-0001-6398-1641
OpenAlex ID: A5040364707
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
2022 · C.E. Geyer, J.E. Garber, et al. · Annals of Oncology · 523
PDF
Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancer
2020 · H.S. Rugo, F. André, et al. · Annals of Oncology · 198
PDF
Management of patients with metastatic breast cancer
2011 · Josefina Cruz Jurado, Paula Richart Aznar, et al. · Advances in Therapy · 191
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group
2016 · A. Gronchi, S. Stacchiotti, et al. · Annals of Oncology · 139
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial
2018 · Sandro Pasquali, Chiara Colombo, et al. · European Journal of Cancer · 89
SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)
2021 · A. de Juan Ferré, R. Álvarez Álvarez, et al. · Clinical & Translational Oncology · 58
Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas: A Nonrandomized Phase 1/2 Clinical Trial
2020 · Javier Martin-Broto, Nadia Hindi, et al. · JAMA Oncology · 50
PDF
SEOM Clinical Guideline of management of soft-tissue sarcoma (2016)
2016 · A. López-Pousa, J. Martin Broto, et al. · Clinical & Translational Oncology · 42
PDF
Effectiveness and Safety of Trabectedin and Radiotherapy for Patients With Myxoid Liposarcoma: A Nonrandomized Clinical Trial
2023 · Roberta Sanfilippo, Nadia Hindi, et al. · JAMA Oncology · 33
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY
2023 · Judith Balmaña, Peter A. Fasching, et al. · Breast Cancer Research and Treatment · 27
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial
2022 · Debu Tripathy, Sara M. Tolaney, et al. · JAMA Oncology · 25
Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS)
2023 · Rosa Álvarez Álvarez, Aránzazu Manzano, et al. · Cancers · 23
PDF
Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS –GROUP). Part II
2021 · Javier Martínez-Trufero, Josefina Cruz Jurado, et al. · Cancer Treatment Reviews · 23
Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations for diagnosis and treatment. Spanish group for Sarcoma research (GEIS – GROUP). Part I
2021 · Javier Martínez-Trufero, Josefina Cruz Jurado, et al. · Cancer Treatment Reviews · 17
ImmunoSarc2: A Spanish Sarcoma Group (GEIS) phase Ib trial of doxorubicin and dacarbazine plus nivolumab in first line treatment of advanced leiomyosarcoma.
2023 · Javier Martin Broto, Roberto Diaz Beveridge, et al. · Journal of Clinical Oncology · 13
PDF
Pharmacokinetics of Trastuzumab After Subcutaneous and Intravenous Administration in Obese Patients
2020 · Jonathan González García, Fernando Gutiérrez Nicolás, et al. · Annals of Pharmacotherapy · 12
LBA3 Patritumab deruxtecan (HER3-DXd) in early-stage HR+/HER2- breast cancer: Final results of the SOLTI TOT-HER3 window of opportunity trial
2022 · A. Prat, C. Falato, et al. · Annals of Oncology · 11
Real-world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early-stage HER2-positive breast cancer: the NEOPERSUR study
2024 · Alejandro Falcón González, Josefina Cruz Jurado, et al. · Clinical & Translational Oncology · 10
PDF
Second-Line Treatment Options for Patients with Metastatic Triple-Negative Breast Cancer: A Review of the Clinical Evidence
2025 · José Ángel García-Saenz, Álvaro Rodríguez-Lescure, et al. · Targeted Oncology · 9
PDF
Detection of circulating tumor DNA following neoadjuvant chemotherapy and surgery to anticipate early relapse in ER positive and HER2 negative breast cancer: Analysis from the PENELOPE-B trial.
2023 · Nicholas C. Turner, Frederik Marmé, et al. · Journal of Clinical Oncology · 9
PDF
A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study
2021 · Javier Martínez-Trufero, Luis Miguel De Sande-González, et al. · Cancers · 9
Trabectedin and radiotherapy in soft-tissue sarcoma (TRASTS) study: An international, prospective, phase II trial in localized myxoid liposarcoma—A collaborative Spanish (GEIS), Italian (ISG) and French (FSG) group study.
2020 · Alessandro Gronchi, Nadia Hindi, et al. · Journal of Clinical Oncology · 9
Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib
2017 · Arancha Cebrián, Teresa Gómez del Pulgar, et al. · Scientific Reports · 9
Comprehensive clinical characteristics and ctDNA mutational profile analysis of endocrine resistance/sensitivity to adjuvant ET therapy in luminal breast cancer from the GEICAM/2014-03_RegistEM registry.
2024 · Angel Guerrero, Isabel Alvarez, et al. · Journal of Clinical Oncology · 7
Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study
2021 · Luis de la Cruz-Merino, María Gion, et al. · Cancers · 7
PDF
Works count: 86
Citation count: 1,607
H-index: 14
I10-index: 18
Year
Topic
Type